Skip to main content
. Author manuscript; available in PMC: 2013 Jan 3.
Published in final edited form as: Ann Intern Med. 2012 Jul 3;157(1):11–18. doi: 10.7326/0003-4819-157-1-201207030-00004

Table 3.

Cumulative Incidence of Readmission at 30 Days After Incident MI Discharge According to Baseline/Incident MI Characteristics

Characteristic Hazard Ratio
(95% CI)
Cumulative Incidence
(95% CI)
Age (years)
<60 1 (referent) 19.1 (16.0–22.3)
60–79 0.90 (0.71–1.14) 17.4 (15.5–19.4)
≥80 1.07 (0.80–1.42) 19.9 (16.9–22.8)
Sex
Female 1 (referent) 20.2 (18.0–22.4)
Male 0.83 (0.69–1.00) 17.2 (15.4–19.1)
Hypertension
No 1 (referent) 17.1 (14.7–19.5)
Yes 1.15 (0.94–1.40) 19.3 (17.5–21.1)
Diabetes mellitus
No 1 (referent) 17.3 (15.8–18.8)
Yes 1.34 (1.10–1.63) 22.6 (19.5–25.6)
Chronic obstructive pulmonary disease
No 1 (referent) 17.6 (16.2–19.0)
Yes 1.43 (1.15–1.79) 23.9 (19.9–27.9)
Current smoker
No 1 (referent) 18.2 (16.7–19.7)
Yes 1.11 (0.89–1.39) 19.7 (16.4–22.9)
Cerebrovascular Disease
No 1 (referent) 18.4 (16.9–19.9)
Yes 1.04 (0.83–1.30) 19.2 (15.8–22.5)
Heart failure
No 1 (referent) 18.3 (16.8–19.8)
Yes 1.12 (0.87–1.43) 20.0 (16.2–23.7)
Body mass index (kg/m2)
<20 1.03 (0.70–1.52) 18.4 (12.9–23.9)
20 to 24.9 1.19 (0.94–1.50) 20.1 (17.4–22.9)
25 to 29.9 1.07 (0.87–1.32) 18.5 (16.2–20.8)
≥30 1 (referent) 17.3 (14.9–19.7)
Type of myocardial infarction
ST-segment elevation 0.87 (0.71–1.06) 17.1 (14.6–19.5)
Non ST-segment elevation 1 (referent) 19.2 (17.5–20.9)
Killip class
1 1 (referent) 17.6 (16.0–19.3)
2–4 1.22 (1.01–1.46) 20.5 (17.9–23.0)
Angiography/ Reperfusion/revascularization
Reperfusion/revascularization no complications 1 (referent) 16.8 (14.8–18.7)
Angiogram no complications 1.13 (0.91–1.40) 16.3 (12.8–19.8)
No angiogram/reperfusion/revascularization 1.17 (0.92–1.48) 18.7 (15.7–21.8)
Angiogram with complications 2.40 (1.43–4.01) 35.3 (21.6–49.0)
Reperfusion/ revascularization with complications 2.12 (1.61–2.80) 31.6 (25.4–37.9)
Anemia*
No 1 (referent) 20.9 (18.3–23.6)
Yes 1.26 (1.03–1.50) 17.4 (15.8–19.1)
Estimated glomerular filtration rate (mL/min)*
≥60 1 (referent) 17.5 (15.4–19.6)
<60 1.13 (0.93–1.37) 19.4 (17.4–21.3)
Length of stay during incident MI admission (days)
0–3 1 (referent) 14.4 (11.8–17.0)
4–7 1.34 (1.05–1.70) 18.5 (16.4–21.7)
>7 1.65 (1.27–2.14) 22.0 (19.3–24.7)
Year of diagnosis
1987–92 1 (referent) 18.6 (15.6–21.7)
1993–98 1.03 (0.80–1.33) 18.7 (15.8–21.5)
1999–2004 1.02 (0.79–1.32) 18.8 (16.2–21.3)
2005–10 0.98 (0.74–1.29) 18.1 (15.3–20.9)

The estimated cumulative incidence and 95% CI of readmission at 30 days for each characteristic are adjusted for all other variables shown as well as site of care. CI= confidence interval

*

Anemia and estimated glomerular filtration rate are based on hemoglobin and creatinine from laboratory measurements on the index MI date or the closest date when measured during the index admission.